DoseRoutine supplement library logoDoseRoutine
supplementInjectableNot FDA-approvedResearch chemicalResearch chemical — not approved for human use anywhereNo published human safety or pharmacokinetic data

SLU-PP-332Benefits, Dosage & Interactions

Also known as: exercise mimetic, ERR agonist

SLU-PP-332 is a supplement typically taken orally or as directed. It is most commonly tracked for metabolic and performance. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.

How much SLU-PP-332 do people take?

No human study exists. The rodent work reports milligram-per-kilogram amounts given by injection, which do not translate to a human amount. Route reported: Intraperitoneal injection in the published animal work. Frequency reported: Daily or twice daily in the rodent protocols. These are amounts documented in the cited studies and labels for SLU-PP-332 — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

See the full reported protocol and its sources

Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.

Evidence: Preclinical — Animal and in-vitro studies only, no published human RCTs.
Evidence strengthPreclinical · 1/4
PreclinicalStrong human evidence

Animal and in-vitro studies only, no published human RCTs.

Plasma half-life
Short in rodents; not established in humans
Default unit
mg

What published protocols report

Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.

Reported amounts
No human study exists. The rodent work reports milligram-per-kilogram amounts given by injection, which do not translate to a human amount[1][2]
Route studied
Intraperitoneal injection in the published animal work[1][2]
Frequency
Daily or twice daily in the rodent protocols[1][2]
Cycle length
Days to weeks in the animal models[1][2]
Half-life
Short in rodents; not established in humans[1][2]
Storage
Dry, cool, protected from light[1][2]

Reported for SLU-PP-332 in the cited sources. Published ranges are not dosing advice.

Mixing SLU-PP-332: bacteriostatic water and syringe units

The vial arrives as dry powder. How much water you add sets the strength, and the strength sets the mark you draw to on the syringe. The table assumes a 5 mg vial and a 250 mcg example draw on a U-100 insulin syringe, where 100 units is one millilitre. If your vial is a different size, scale it — the arithmetic is the same.

Bacteriostatic water addedResulting strength250 mcg draws to
1 mL5 mg/mL5 units
2 mL2.5 mg/mL10 units
3 mL1.67 mg/mL15 units

Units, not millilitres. Insulin syringes are marked in units, and mixing up mcg and mg on a peptide label is the single most common error people report. Check the label twice. Run your own vial through the calculator.

Storage and stability

Before mixing
Sealed and still as a dry powder, SLU-PP-332 vials are normally kept in the fridge at 2–8 °C, out of light. Short spells at room temperature during shipping are the norm for lyophilized peptides and are not, on their own, a sign the vial is spoiled.
After mixing
Once bacteriostatic water goes in, the vial belongs in the fridge and is generally treated as good for about 28 days — that is how long the benzyl alcohol in bacteriostatic water is relied on to hold back bacterial growth. Plain sterile water has no preservative, so a vial mixed with it is a single-session vial. Never freeze a reconstituted vial.
When to throw it out
A properly mixed vial is clear. Cloudiness, floating strands, a color change or powder that will not go into solution after gentle swirling all mean the vial should be discarded rather than used. Shaking a peptide vial hard is the usual cause — swirl it, or run the water down the inside wall of the vial instead of onto the powder.

Handling and shelf-life figures describe general practice for lyophilized peptides. They are not a dose and not medical advice — your prescriber or the product label sets the amount.

References & evidence

Documents the SLU-PP-332 entry is written from. Each number matches an inline marker above.

  1. [1]Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise CapacityBillon C, et al. · ACS Chemical Biology · 2023 · Peer-reviewed · PMID 36988910
  2. [2]A Synthetic ERR Agonist Alleviates Metabolic SyndromeBillon C, et al. · Journal of Pharmacology and Experimental Therapeutics · 2024 · Peer-reviewed · PMID 37739806

What is SLU-PP-332?

SLU-PP-332 is catalogd in DoseRoutine as a supplement. A detailed evidence-based summary is being prepared from NIH, Mayo Clinic, FDA label and PubChem sources.

What interacts with SLU-PP-332?

Documented interactions for SLU-PP-332: the other compound, the severity and confidence of the interaction, what happens, and what to do.
Interacts withSeverityTypeWhat happensWhat to do
Any glp1 + supplementNoteCategory ruleConfidence: theoreticalGLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.Source pendingTime oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider.
Any supplement + medicationNoteCategory ruleConfidence: theoreticalSome supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pendingSpecific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.

Frequently asked questions about SLU-PP-332

SLU-PP-332 is a supplement. It is also known as exercise mimetic and ERR agonist. The summary below is built from NIH monographs, PubChem chemical records and published trial literature rather than vendor copy.

SLU-PP-332 is commonly discussed in the context of supporting metabolic and performance. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.

For SLU-PP-332, it is typically taken null. Always follow the specific dose your clinician or the product label prescribes.

SLU-PP-332 carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.

Interaction risk for SLU-PP-332 comes from the rest of the stack: other supplements, prescription medicines, hormone therapy and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers SLU-PP-332 with no sign-up.

There is no single answer for SLU-PP-332 plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions

Pairing SLU-PP-332 with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.

Published frequency for SLU-PP-332 varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps

The effect of a missed dose of SLU-PP-332 depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.

For SLU-PP-332 the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.

No human study exists. The rodent work reports milligram-per-kilogram amounts given by injection, which do not translate to a human amount. Route reported: Intraperitoneal injection in the published animal work. Frequency reported: Daily or twice daily in the rodent protocols. These are amounts documented in the cited studies and labels for SLU-PP-332 — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

Verify at

Publisher search links for SLU-PP-332. These are places to check the information — they are not citations, so they are not numbered.

DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.

What is the short answer on SLU-PP-332?

Plain-text summary, safe to quote verbatim:

SLU-PP-332 is a supplement typically taken orally or as directed. It is most commonly tracked for metabolic and performance. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.
Source: DoseRoutine — https://doseroutine.com/library/slu-pp-332

Cite this page

Using this in an article, AI answer, or research note? Please attribute:

DoseRoutine. (2026). SLU-PP-332 — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/slu-pp-332
Canonical URL

What compounds are similar to SLU-PP-332?

Others in the supplement category or studied for the same goals.

Track SLU-PP-332 in DoseRoutine

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →

Latest research from DoseRoutine

Browse all DoseRoutine research updates

Track SLU PP 332 in your own routine

Add SLU PP 332 to your stack, get reminders at the right times, and see interaction notes with everything else you take. Free to start — no card needed.

Track SLU PP 332 freeSign in